切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inhibitor of apoptosis proteins (IAP) - Vitamin D receptors (VDRs) - RET - 5-HT2 Receptor

14件产品中的 1-10

页面
每页
清除全部
  1. SM-164
    A8815 SM-164
     8 Citation
    Target: Inhibitor of apoptosis proteins (IAP)
    Summary: 抗癌药
      ≥56.07 mg/mL
      insoluble in H2O
  2. SCH 23390 hydrochloride
    B6506 SCH 23390 hydrochloride
    Target: dopamine receptor|5-HT1 Receptor|5-HT2 Receptor
    Summary: 多巴胺受体拮抗剂
      Soluble to 100 mM in sterile water and to 50 mM in ethanol
  3. Methylergometrine maleate
    B6347 Methylergometrine maleate
    中文名: 马来酸甲麦角新碱
    Target: 5-HT1 Receptor|5-HT2 Receptor
    Summary: 5-HT1/5-HT2受体拮抗剂
      Soluble to 25 mM in H2O
  4. Calcifediol
    B2140 Calcifediol
    中文名: 骨化二醇
    Target: Vitamin D receptors (VDRs)
    Summary: 维生素D3的主要循环形式
      ≥13.65 mg/mL
      insoluble in H2O
  5. Doxercalciferol
    B2091 Doxercalciferol
     1 Citation
    中文名: 度骨化醇
    Target: Vitamin D receptors (VDRs)
    Summary: 维生素D受体激活剂
      ≥11.5 mg/mL
      insoluble in H2O
  6. Lithocholic Acid
    A8463 Lithocholic Acid
    中文名: 石胆酸
    Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)
    Summary: 维生素D受体PXR和FXR的激活剂
      ≥12.95 mg/mL
      insoluble in H2O
  7. Lenvatinib (E7080)
    A2174 Lenvatinib (E7080)
    中文名: 乐伐替尼,仑伐替尼
    Target: VEGFR|PDGFR|RET
    Summary: VEGFR抑制剂
      ≥21.35 mg/mL
      insoluble in H2O
  8. Regorafenib
    A8236 Regorafenib
     4 Citation
    中文名: 瑞戈非尼
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
      ≥25.04 mg/mL
      insoluble in H2O
  9. LCL161
    A3541 LCL161
     1 Citation
    Target: Inhibitor of apoptosis proteins (IAP)
    Summary: IAPs拮抗剂
      ≥25.05 mg/mL
      insoluble in H2O
  10. Ercalcitriol
    A3396 Ercalcitriol
    Target: Vitamin D receptors (VDRs)
    Summary: 维生素D2的活性代谢物
      Soluble in ethanol

14件产品中的 1-10

页面
每页